![]() |
|
|
Vol. 285, Issue 1, 242-246, April 1998
Department of Clinical Pharmacokinetics, Division of Pharmaceutical
Science, Kyushu University, 3-1-1, Maidashi, Higashi-Ku, Fukuoka, 812 Japan (S.O., N.A., T.F., E.Y., S.H.);
Department of Clinical
Pharmacology and Therapeutics, Oita Medical University, Hasama-Machi,
Oita 879-55, Japan (S.N.) and
Department of Pharmacology, Ehime
University School of Medicine, Shigenobu-Cho, Onsen-Gun, Ehime 791-02 (N.O.)
The role of the sensitivity of bone marrow cells to, and the
pharmacokinetics of granulocyte colony-stimulating factor (G-CSF) on
the rhythm of leukocyte-increasing effect was investigated in ICR male
mice housed under a standardized light-dark cycle (lights on at 0700, off at 1900). A significant circadian rhythm was demonstrated for
leukocyte counts at 24 hr after G-CSF (250 µg/kg, s.c.) injection at
six different circadian times (P < .01). The leukocyte counts of
mice given G-CSF at 0500, 0900, 1300 or 1700 were significantly higher
than those of mice given G-CSF at 2100 (P < .01, respectively).
The rhythmic pattern resembled overall the rhythm occurring after
saline injection. In the comparison between leukocyte counts after
G-CSF injection at 0700 and 1900, the time when leukocyte counts are
equal in nondrugged state, the leukocyte counts at 24 hr after G-CSF
(250 µg/kg, i.v.) injection were approximately 50% higher in mice
injected with the drug at 0700 than at 1900 (P < .01). Bone
marrow cultures obtained at two times of day resulted in different
numbers of myeloid colonies even when treated with the same
concentrations of G-CSF in vitro. The colony-forming
activity of G-CSF was significantly more potent at 0700 than at 1900 (P < .01). The plasma G-CSF concentrations after G-CSF (250 or 5 µg/kg, i.v.) injection were significantly higher in mice receiving
injections with the drug at 0700 than at 1900 (P < .05, respectively). The area under the curve and mean residence time were
significantly larger in mice injected with the drug at 0700 than at
1900 (P < .01, P < .05, respectively). Our suggests that
the rhythm of G-CSF activity is caused by that of the sensitivity of
bone marrow cells to, and the pharmacokinetics of the drug.
This article has been cited by other articles:
![]() |
T. Akagi, K. Ushinohama, S. Ikesue, E. Yukawa, S. Higuchi, K. Hamase, K. Zaitsu, and S. Ohdo Chronopharmacology of Melatonin in Mice to Maximize the Antitumor Effect and Minimize the Rhythm Disturbance Effect J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 378 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, S. Ohdo, H. Takane, Y. Tomiyoshi, A. Matsuo, E. Yukawa, and S. Higuchi Chronopharmacology of Analgesic Effect and Its Tolerance Induced by Morphine in Mice J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1200 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohdo, D.-S. Wang, S. Koyanagi, H. Takane, K. Inoue, H. Aramaki, E. Yukawa, and S. Higuchi Basis for Dosing Time-Dependent Changes in the Antiviral Activity of Interferon-alpha in Mice J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 488 - 493. [Abstract] [Full Text] |
||||
![]() |
H. Takane, S. Ohdo, T. Yamada, E. Yukawa, and S. Higuchi Chronopharmacology of Antitumor Effect Induced by Interferon-beta in Tumor-Bearing Mice J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 746 - 752. [Abstract] [Full Text] |
||||